Welcome to Mundipharma

This website is intended to provide information for Mundipharma’s global business. Please visit our regional websites for access to regional and country specific information.

About Us


Mundipharma is a global (ex-US) network of independent associated companies that research, develop and manufacture innovative pharmaceutical medicines and consumer healthcare products. We are an agile and fast-paced company seeking to increase access to health care through programmes and effective partnerships.

We are forward-looking and dedicated to bringing innovative treatments to many of the world’s most challenging conditions and diseases including: Pain Management & Supportive Care, Consumer Health, Anti-Infectives, Biosimilars, CNS, Diabetes, Oncology, Ophthalmology, Respiratory and transplantation immunity.

We make a difference to patient lives by delivering value to healthcare professionals in 120+ countries across Africa, Asia Pacific, Canada, Europe, Latin America and the Middle East.

Our guiding principles, centred around Integrity and Patient-Centricity, are at the heart of everything we do. We encourage our people to think differently and our inclusive culture of continuous learning and collaboration make Mundipharma a great place to work.

Latest News

Orphan Drug Designation granted to rezafungin in EU

Jan 26 2021

STRICTLY FOR MEDICAL AND PHARMACEUTICAL TRADE MEDIA ONLY

Julie Dehaene-Puype and Erik Nordkamp appointed as new regional Commercial Officers for Mundipharma

Jan 19 2021

Mundipharma ranked one of the 2020 Best Workplaces in Europe by Great Place to Work®

Sep 11 2020

Over 4,000 employees

Presence in 124 countries

Revenues in excess of $2 billion

Regional websites

For more information please visit our regional websites

“Mundipharma is at an exciting point in its transformational journey. One focussed on creating a culture of innovation and differentiation, where every individual employee counts and can make a real difference.”
Marc Princen, Global CEO